{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:10:20Z","timestamp":1792786220521,"version":"4.5.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Stichting Hartekind","id":[{"id":"https:\/\/ror.org\/00s3sar63","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Sebald Fund and the Dutch Heart Foundation","award":["NHS2013-T091"],"award-info":[{"award-number":["NHS2013-T091"]}],"id":[{"id":"https:\/\/ror.org\/05nxhgm70","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation","id":[{"id":"https:\/\/ror.org\/05nxhgm70","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012524","name":"Dutch Federation of University Medical Centers","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012524","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001722","name":"Royal Netherlands Academy of Sciences","doi-asserted-by":"crossref","award":["CVON-2012-08"],"award-info":[{"award-number":["CVON-2012-08"]}],"id":[{"id":"10.13039\/501100001722","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.ijcard.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,8]],"date-time":"2019-04-08T11:28:17Z","timestamp":1554722897000},"page":"96-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Right ventricular pressure overload alters cardiac lipid composition"],"prefix":"10.1016","volume":"287","author":[{"given":"A.M.C.","family":"Koop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.A.J.","family":"Hagdorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.P.L.","family":"Bossers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"van Leusden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gerding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"van Weeghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.M.","family":"Vaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.P.Y.","family":"Koonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.H.W.","family":"Sillj\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bartelds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.04.004_bb0005","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1093\/eurheartj\/ehl477","article-title":"Prognostic value of right ventricular mass, volume, and function in idiopathic pulmonary arterial hypertension","volume":"28","author":"Van Wolferen","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0010","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.amjcard.2005.10.065","article-title":"Incidence and risk distribution of heart failure in adolescents and adults with congenital heart disease after cardiac surgery","volume":"97","author":"Norozi","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0015","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jacc.2016.10.047","article-title":"The relationship between the right ventricle and its load in pulmonary hypertension","volume":"69","author":"Vonk Noordegraaf","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0020","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.yjmcc.2014.11.024","article-title":"Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction","volume":"79","author":"Borgdorff","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0025","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1161\/CIRCRESAHA.113.301129","article-title":"The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure","volume":"115","author":"Ryan","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10741-015-9479-6","article-title":"Right ventricular failure due to chronic pressure load: what have we learned in animal models since the NIH working group statement?","volume":"20","author":"Borgdorff","year":"2015","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0035","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1161\/CIRCULATIONAHA.112.155887","article-title":"Right ventricle: wrong targets? Another blow for pharmacotherapy in congenital heart diseases","volume":"127","author":"Roche","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0040","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ijcard.2013.08.102","article-title":"A cornerstone of heart failure treatment is not effective in experimental right ventricular failure","volume":"169","author":"Borgdorff","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0045","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1161\/CIRCULATIONAHA.112.135392","article-title":"Effect of valsartan on systemic right ventricular function: a double-blind, randomized, placebo-controlled pilot trial","volume":"127","author":"Van Der Bom","year":"2013","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00109-009-0524-6","article-title":"The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodelling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle","volume":"88","author":"Piao","year":"2010","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0055","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00109-013-1064-7","article-title":"Cardiac glutaminolysis: a maladaptive cancer metabolism pathway in the right ventricle in pulmonary hypertension","volume":"91","author":"Piao","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1164\/rccm.201507-1444OC","article-title":"Mechanisms of lipid accumulation in the bone morphogenetic protein receptor type 2 mutant right ventricle","volume":"194","author":"Talati","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.14814\/phy2.13157","article-title":"Estrogen maintains mitochondrial content and function in the right ventricle of rats with pulmonary hypertension","volume":"5","author":"Liu","year":"2017","journal-title":"Physiol. Rep."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0070","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.cardiores.2007.05.012","article-title":"Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species","volume":"75","author":"Redout","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0075","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/pmic.200401313","article-title":"Proteomic changes in the pressure overloaded right ventricle after 6 weeks in young rats: correlations with the degree of hypertrophy","volume":"5","author":"Faber","year":"2005","journal-title":"Proteomics."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0080","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00109-013-1059-4","article-title":"A metabolic remodelling in right ventricular hypertrophy is associated with decreased angiogenesis and a transition from a compensated to a decompensated state in pulmonary hypertension","volume":"91","author":"Sutendra","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0085","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jtcvs.2008.01.040","article-title":"A dynamic and chamber-specific mitochondrial remodelling in right ventricular hypertrophy can be therapeutically targeted","volume":"136","author":"Nagendran","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0090","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1161\/CIRCHEARTFAILURE.111.966127","article-title":"Metabolic gene remodelling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension","volume":"6","author":"Gomez-Arroyo","year":"2013","journal-title":"Circ. Hear. Fail."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0095","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1164\/rccm.201306-1086OC","article-title":"Evidence for right ventricular lipotoxicity in heritable pulmonary arterial hypertension","volume":"189","author":"Hemnes","year":"2014","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0100","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1161\/CIRCULATIONAHA.115.020696","article-title":"Bone morphogenetic protein receptor type 2 mutation in pulmonary arterial hypertensionCLINICAL PERSPECTIVE","volume":"133","author":"van der Bruggen","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0105","doi-asserted-by":"crossref","DOI":"10.1007\/s10741-016-9526-y","article-title":"The right ventricle and pulmonary hypertension","author":"van de Veerdonk","year":"2016","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ejphar.2006.08.016","article-title":"Prostacyclin therapy increases right ventricular capillarisation in a model for flow-associated pulmonary hypertension","volume":"549","author":"van Albada","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0115","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cardfail.2015.09.001","article-title":"Differential mitochondrial function in remodeled right and nonremodeled left ventricles in pulmonary hypertension","volume":"22","author":"Gupte","year":"2016","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1152\/physiolgenomics.00185.2004","article-title":"Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure","volume":"21","author":"Buermans","year":"2005","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ijcard.2019.04.004_bb0125","first-page":"1676","article-title":"Impaired regional fatty acid uptake and systolic dysfunction in hypertrophied right ventricle","volume":"39","author":"Nagaya","year":"1998","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0130","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.bbamcr.2011.01.015","article-title":"Targeting fatty acid and carbohydrate oxidation - a novel therapeutic intervention in the ischemic and failing heart","volume":"1813","author":"Jaswal","year":"2011","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0135","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbamcr.2012.08.014","article-title":"Targeting mitochondrial oxidative metabolism as an approach to treat heart failure","volume":"1833","author":"Fillmore","year":"2013","journal-title":"Biochim. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0140","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1136\/hrt.2010.214932","article-title":"Metabolic modulation in heart failure: high time for a definitive clinical trial","volume":"97","author":"Ashrafian","year":"2011","journal-title":"Heart."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0145","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/CIRCULATIONAHA.105.551457","article-title":"Metabolic modulation with perhexiline in chronic heart failure: a randomized, controlled trial of short-term use of a novel treatment","volume":"112","author":"Lee","year":"2005","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0150","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1111\/j.1582-4934.2009.00759.x","article-title":"Metabolic modulation and cellular therapy of cardiac dysfunction and failure","volume":"13","author":"Revenco","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0155","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.yjmcc.2014.11.024","article-title":"Clinical symptoms of right ventricular failure in experimental chronic pressure load are associated with progressive diastolic dysfunction","volume":"79","author":"Borgdorff","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0160","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1194\/jlr.M067470","article-title":"Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios","volume":"57","author":"Herzog","year":"2016","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0165","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ab.2009.01.032","article-title":"Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome","volume":"387","author":"Houtkooper","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0170","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1161\/CIRCHEARTFAILURE.112.971168","article-title":"Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodelling by interfering with myocardial fibrogenesis","volume":"6","author":"Yu","year":"2013","journal-title":"Circ. Hear. Fail."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0175","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1194\/jlr.M800561-JLR200","article-title":"Cardiolipin biosynthesis and remodelling enzymes are altered during development of heart failure","volume":"50","author":"Saini-Chohan","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0180","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.yjmcc.2014.06.002","article-title":"Dysregulation of cardiolipin biosynthesis in pediatric heart failure","volume":"74","author":"Chatfield","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0185","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/ana.10176","article-title":"Deficiency of tetralinoleoyl-cardiolipin in Barth Syndrome","volume":"51","author":"Schlame","year":"2002","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0190","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.1021\/bi7004015","article-title":"Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study","volume":"46","author":"Han","year":"2007","journal-title":"Biochemistry."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0195","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1194\/jlr.M600551-JLR200","article-title":"Loss of cardiac tetralinoleoyl cardiolipin in human and experimental heart failure","volume":"48","author":"Sparagna","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0200","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0003-2697(91)90332-N","article-title":"Analysis of cardiolipin molecular species by high-performance liquid chromatography of its derivative 1,3-bisphosphatidyl-2-benzoyl-sn-glycerol dimethyl ester","volume":"195","author":"Schlame","year":"1991","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0205","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.chemphyslip.2005.08.002","article-title":"Molecular symmetry in mitochondrial cardiolipins","volume":"138","author":"Schlame","year":"2005","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.ijcard.2019.04.004_bb0210","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1007\/s00018-008-8030-5","article-title":"Cardiolipin, the heart of mitochondrial metabolism","volume":"65","author":"Houtkooper","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0215","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cvr\/cvw176","article-title":"Mitochondrial complex I dysfunction and altered NAD(P)H kinetics in rat myocardium in cardiac right ventricular hypertrophy and failure","volume":"111","author":"W\u00fcst","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0220","doi-asserted-by":"crossref","first-page":"H1415","DOI":"10.1152\/ajpheart.00247.2011","article-title":"Persistent pulmonary hypertension results in reduced tetralinoleoyl-cardiolipin and mitochondrial complex II + III during the development of right ventricular hypertrophy in the neonatal pig heart","volume":"301","author":"Saini-Chohan","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0225","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.freeradbiomed.2008.09.031","article-title":"Mitochondrial complex I dysfunction in rat heart with aging: critical role of reactive oxygen species and cardiolipin","volume":"46","author":"Petrosillo","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0230","series-title":"Decreased Complex III Activity in Mitochondria Isolated From Rat Heart Subjected to Ischemia and Reperfusion : Role of Reactive Oxygen Species and Cardiolipin 1","first-page":"714","author":"Petrosillo","year":"2003"},{"key":"10.1016\/j.ijcard.2019.04.004_bb0235","series-title":"The Effect of Reactive Oxygen Species Generated From the Mitochondrial Electron Transport Chain on the Cytochrome c Oxidase Activity and on the Cardiolipin Content in Bovine Heart Submitochondrial Particles","first-page":"323","volume":"466","author":"Paradies","year":"2000"},{"key":"10.1016\/j.ijcard.2019.04.004_bb0240","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.bbabio.2008.05.444","article-title":"Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat","volume":"1777","author":"Lesnefsky","year":"2008","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0245","doi-asserted-by":"crossref","first-page":"E704","DOI":"10.1152\/ajpendo.2001.281.4.E704","article-title":"Electrostimulation enhances FAT\/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes","volume":"281","author":"Luiken","year":"2001","journal-title":"Am. J. Physiol. - Endocrinol. Metab."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbalip.2016.03.018","article-title":"The role of CD36 in the regulation of myocardial lipid metabolism","author":"Kim","year":"2016","journal-title":"BBA - Mol. Cell Biol. Lipids."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0816-2","article-title":"SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart","volume":"18","author":"Li","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0260","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11010-008-9803-8","article-title":"Oxidative stress mediates cardiac fibrosis by enhancing transforming growth factor-beta1 in hypertensive rats","volume":"317","author":"Zhao","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0265","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.cardiores.2006.03.016","article-title":"NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure","volume":"71","author":"Murdoch","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0270","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1093\/eurheartj\/ehv305","article-title":"Pathophysiological role of oxidative stress in systolic and diastolic heart failure and its therapeutic implications","volume":"36","author":"M\u00fcnzel","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-017-0615-6","article-title":"Impact of empagliflozin on subclinical left ventricular dysfunctions and on the mechanisms involved in myocardial disease progression in type 2 diabetes: rationale and design of the EMPA-HEART trial","volume":"16","author":"Natali","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0280","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jtcvs.2008.08.056","article-title":"Acute hyperglycaemia enhances oxidative stress and exacerbates myocardial infarction by activating NADPH oxidase during reperfusion","volume":"137","author":"Yang","year":"2010","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0285","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","article-title":"Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II\u2013induced cardiac hypertrophy","volume":"93","author":"Byrne","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0290","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cardfail.2015.04.016","article-title":"Short-term caloric restriction suppresses cardiac oxidative stress and hypertrophy caused by chronic pressure overload","volume":"21","author":"Kobara","year":"2015","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0295","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/db06-1163","article-title":"Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: The role of angiotensin type 1 receptor antagonism","volume":"56","author":"Rutschow","year":"2007","journal-title":"Diabetes."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0300","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.7150\/thno.26055","article-title":"Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production","volume":"8","author":"Du","year":"2018","journal-title":"Theranostics."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0305","doi-asserted-by":"crossref","first-page":"H71","DOI":"10.1152\/ajpheart.1999.276.1.H71","article-title":"Adaptation to hypoxia alters energy metabolism in rat heart","volume":"276","author":"Rumsey","year":"1999","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0310","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cardiores.2004.12.023","article-title":"Time course of differential mitochondrial energy metabolism adaptation to chronic hypoxia in right and left ventricles","volume":"66","author":"Nouette-Gaulain","year":"2005","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0315","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00109-011-0804-9","article-title":"Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle","volume":"90","author":"Fang","year":"2012","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0320","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00109-012-0982-0","article-title":"FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate","volume":"91","author":"Piao","year":"2013","journal-title":"J. Mol. Med. (Berl)."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0325","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cvr\/cvs118","article-title":"Dietary linoleate preserves cardiolipin and attenuates mitochondrial dysfunction in the failing rat heart","volume":"94","author":"Mulligan","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0330","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.108.114264","article-title":"Linoleate-rich high-fat diet decreases mortality in hypertensive heart failure rats compared with lard and low-fat diets","volume":"52","author":"Chicco","year":"2008","journal-title":"Hypertension."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0335","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1113\/jphysiol.2012.230490","article-title":"Improvements in skeletal muscle strength and cardiac function induced by resveratrol during exercise training contribute to enhanced exercise performance in rats","volume":"590","author":"Dolinsky","year":"2012","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0340","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1161\/CIRCULATIONAHA.111.067801","article-title":"The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice","volume":"125","author":"Qin","year":"2012","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0345","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1113\/jphysiol.2013.270538","article-title":"Impairments in mitochondrial palmitoyl-CoA respiratory kinetics that precede development of diabetic cardiomyopathy are prevented by resveratrol in ZDF rats","volume":"592","author":"Beaudoin","year":"2014","journal-title":"J. Physiol."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0350","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s10557-008-6141-8","article-title":"Resveratrol attenuates ventricular arrhythmias and improves the long-term survival in rats with myocardial infarction","volume":"22","author":"Chen","year":"2008","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ijcard.2019.04.004_bb0355","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.bbalip.2016.03.008","article-title":"Cardiac mitochondrial energy metabolism in heart failure: role of cardiolipin and sirtuins","volume":"1861","author":"Dolinsky","year":"2016","journal-title":"Biochim. Biophys. Acta - Mol. Cell Biol. Lipids."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318364386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527318364386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:42:23Z","timestamp":1759092143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527318364386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":71,"alternative-id":["S0167527318364386"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.004","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Right ventricular pressure overload alters cardiac lipid composition","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}